Erytech Pharma sets IPO pricing terms

Erytech Pharma, a French biopharmaceutical company, has priced its IPO of up to 4.26 million shares at between $23 and $24 per share. Erytech plans on listing the stock on the NASDAQ under the ticker symbol “ERYP.” Jefferies and Cowen & Company are among the underwriters. Erytech’s backers include Auriga Partners.

North AmericaUSBriefs